These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25545245)

  • 1. Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
    Rath T; Zwaschka L; Hage L; Kügler M; Menendez K; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2014; 9(12):e115847. PubMed ID: 25545245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease.
    Rath T; Menendez KM; Kügler M; Hage L; Wenzel C; Schulz R; Graf J; Nährlich L; Roeb E; Roderfeld M
    Dig Liver Dis; 2012 Sep; 44(9):780-7. PubMed ID: 22652148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation.
    Roderfeld M; Rath T; Schulz R; Seeger W; Tschuschner A; Graf J; Roeb E
    J Cyst Fibros; 2009 Sep; 8(5):338-47. PubMed ID: 19604728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.
    Hector A; Kormann MS; Mack I; Latzin P; Casaulta C; Kieninger E; Zhou Z; Yildirim AÖ; Bohla A; Rieber N; Kappler M; Koller B; Eber E; Eickmeier O; Zielen S; Eickelberg O; Griese M; Mall MA; Hartl D
    PLoS One; 2011; 6(9):e24399. PubMed ID: 21949714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.
    Rath T; Roderfeld M; Güler C; Wenzel C; Graf J; Beitinger F; Roeb E; Zachoval R
    Scand J Gastroenterol; 2011 Nov; 46(11):1369-80. PubMed ID: 21905976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.
    Fantino E; Gangell CL; Hartl D; Sly PD;
    BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers in early-stage and locally advanced melanoma.
    Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
    Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome.
    Kastelijn EA; van Moorsel CH; Ruven HJ; Korthagen NM; Kwakkel-van Erp JM; van de Graaf EA; Zanen P; van Kessel DA; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):28-35. PubMed ID: 24003532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40 as marker of severe lung disease in cystic fibrosis patients.
    Leonardi S; Parisi GF; Capizzi A; Manti S; Cuppari C; Scuderi MG; Rotolo N; Lanzafame A; Musumeci M; Salpietro C
    J Cyst Fibros; 2016 Sep; 15(5):583-6. PubMed ID: 26778616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis.
    Devereux G; Steele S; Jagelman T; Fielding S; Muirhead R; Brady J; Grierson C; Brooker R; Winter J; Fardon T; McCormick J; Huang JT; Miller D
    J Cyst Fibros; 2014 Sep; 13(5):557-63. PubMed ID: 24525080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.
    Jackson PL; Xu X; Wilson L; Weathington NM; Clancy JP; Blalock JE; Gaggar A
    Mol Med; 2010; 16(5-6):159-66. PubMed ID: 20111696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum YKL-40 level and dysglycemia in cystic fibrosis.
    Bouvet GF; Maignan M; Arslanian E; Coriati A; Rabasa-Lhoret R; Berthiaume Y
    Cytokine; 2015 Feb; 71(2):296-301. PubMed ID: 25497736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
    Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled breath condensate MMP-9 levels in children with bronchiectasis.
    Karakoc GB; Inal A; Yilmaz M; Altintas DU; Kendirli SG
    Pediatr Pulmonol; 2009 Oct; 44(10):1010-6. PubMed ID: 19725099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.
    Ratjen F; Hartog CM; Paul K; Wermelt J; Braun J
    Thorax; 2002 Nov; 57(11):930-4. PubMed ID: 12403873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
    Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic Fibrosis.
    Coriati A; Massé C; Ménard A; Bouvet GF; Berthiaume Y
    Inflammation; 2018 Oct; 41(5):1631-1639. PubMed ID: 29804188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sTREM-1 is elevated in cystic fibrosis and correlates with proteases.
    Forrester DL; Barr HL; Fogarty A; Knox A
    Pediatr Pulmonol; 2017 Apr; 52(4):467-471. PubMed ID: 28068000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension.
    Wang D; Lu JG; Wang Q; Du XL; Dong R; Wang P; Zhao L; Jiang X; Yuan LJ
    Braz J Med Biol Res; 2012 Mar; 45(3):264-72. PubMed ID: 22267006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.